Friedman Center for Nutrition
Found 9 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is D  [Clear All Filters]
2023
J Blander M.  2023.  Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.. Semin Immunol. 66:101713.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
2022
Ahmed W, Galati J, Kumar A, Christos PJ, Longman R, Lukin DJ, Scherl E, Battat R.  2022.  Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.. Clin Gastroenterol Hepatol. 20(3):e361-e379.
2021
González-Borja I, Alors-Pérez E, Amat I, Alonso L, Viyuela-García C, Goñi S, Reyes JC, Ceballos-Chávez M, Hernández-García I, Sánchez-Frías ME et al..  2021.  Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma.. Front Med (Lausanne). 8:720128.
Li H, Illés P, Karunaratne CV, Nordstrøm LUlrik, Luo X, Yang A, Qiu Y, Kurland IJ, Lukin DJ, Chen W et al..  2021.  Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics.. Bioorg Chem. 109:104661.
Viladomiu M, Longman RS.  2021.  Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel disease.. J Clin Invest. 131(9)
Altman MC, Rinchai D, Baldwin N, Toufiq M, Whalen E, Garand M, Kabeer BSyed Ahame, Alfaki M, Presnell SR, Khaenam P et al..  2021.  Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data.. Nat Commun. 12(1):4385.
Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J et al..  2021.  Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.. Lancet Gastroenterol Hepatol. 6(10):826-849.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.